A Retrospective Analysis of Rituximab Treatment for B Cell Depletion in Different Pediatric Indications
Background: Rituximab (RTX) is used in cancer therapy as well as in the treatment of autoimmune diseases and alloimmune responses after transplantation. It depletes the disease-causing B cells by binding to the CD (cluster of differentiation) 20 antigen. We evaluate different pediatric treatment pro...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Frontiers Media S.A.
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/dd74fc123dc04d76b105e2bc382a3604 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|